Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do Patients and Physicians Agree When They Assess Quality of Life?
Barata A, Martino R, Gich I, García-Cadenas I, Abella E, Barba P, Briones J, Brunet S, Esquirol A, García-Pallarols F, Garrido A, Granell M, Martinez J, Mensa I, Novelli S, Sánchez-González B, Valcárcel D, Sierra J. Barata A, et al. Biol Blood Marrow Transplant. 2017 Jun;23(6):1005-1010. doi: 10.1016/j.bbmt.2017.03.015. Epub 2017 Mar 10. Biol Blood Marrow Transplant. 2017. PMID: 28288950 Free article.
Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies.
Esquirol A, Pascual MJ, Ortiz M, Piñana JL, Ferra C, Garcia Cadenas I, Vilades I, Brunet S, Martino R, Sierra J. Esquirol A, et al. Bone Marrow Transplant. 2017 Sep;52(9):1273-1279. doi: 10.1038/bmt.2017.111. Epub 2017 Jun 12. Bone Marrow Transplant. 2017. PMID: 28604667
Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature.
García-Cadenas I, Awol R, Esquirol A, Saavedra S, Bosch-Vilaseca A, Novelli S, Garrido A, López J, Granell M, Moreno C, Briones J, Brunet S, Sierra J, Martino R. García-Cadenas I, et al. Bone Marrow Transplant. 2020 Jun;55(6):1041-1049. doi: 10.1038/s41409-019-0771-2. Epub 2019 Dec 10. Bone Marrow Transplant. 2020. PMID: 31822813 Review.
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis.
Fox ML, García-Cadenas I, Pérez AM, Villacampa G, Piñana JL, Ortí G, Montoro J, Roldán E, Bosch Vilaseca A, Martino R, Salamero O, Saavedra S, Hernandez-Boluda JC, Esquirol A, Sierra J, Sanz J, Solano C, Bosch F, Barba P, Valcarcel D. Fox ML, et al. Leuk Lymphoma. 2020 Aug;61(8):1823-1832. doi: 10.1080/10428194.2020.1788015. Epub 2020 Jul 11. Leuk Lymphoma. 2020. PMID: 32654570
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García-Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris CE, O'Dwyer M, Gil JS, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Hemasphere. 2020 Jun 29;4(4):e423. doi: 10.1097/HS9.0000000000000423. eCollection 2020 Aug. Hemasphere. 2020. PMID: 32904089 Free PMC article. No abstract available.
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris EC, O'Dwyer M, Sierra JG, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Hemasphere. 2021 Sep 10;5(10):e642. doi: 10.1097/HS9.0000000000000642. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34522844 Free PMC article.
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.
Reinoso-Segura M, Caballero-Velázquez T, Herrera P, Patriarca F, Fanin R, Bruno B, Einsele H, Nahi H, Granell M, López-Corral L, Reguera JL, García-Cadenas I, Gahrton G, Pérez-Simón JA; European Myeloma Network, the European Society for Blood and Marrow Transplantation, and the Spanish Group of Transplantation. Reinoso-Segura M, et al. Transplant Cell Ther. 2022 May;28(5):258.e1-258.e8. doi: 10.1016/j.jtct.2022.01.026. Epub 2022 Feb 4. Transplant Cell Ther. 2022. PMID: 35131486 Free article. Clinical Trial.
80 results